Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Akaza

Showing results (1-10 of 293) with videos related to

Pageof 30
Sort By:
Cancer Treatment Reviews|June 6, 2003
Combined androgen blockade may have long term survival benefits over monotherapy, but may increase adverse effects and reduce quality of life in advanced prostate cancerH Akaza
Progress in Clinical and Biological Research|January 1, 1990
Response criteria in research protocols for prostatic cancerH Akaza
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 1, 1981
[The significance of lymphocytic infiltration in urologic tumors: studies of distributions of B and T-lymphocytes and its subsets, and functional analysis of the infiltrating lymphocytes (author's transl)]H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 14, 1997
[Development of new drugs for urological cancers]H Akaza
Current Opinion in Urology|September 27, 2000
Advances in chemotherapy of invasive bladder cancerH Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 4, 1999
[A new anti-androgen, bicalutamide (Casodex), for the treatment of prostate cancer--basic clinical aspects]H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 1999
[Recent advancement of the treatment of urological malignancies]H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1996
[Why is prostate cancer important in clinical field, now?]H Akaza
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|February 1, 1994
[TNM classification]H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1988
[Current status of the treatment of urothelial tumors]H Akaza
Pageof 30

Showing results (1-10 of 293) with videos related to

Sort By:
Pageof 30
Cancer Treatment Reviews|June 6, 2003
Combined androgen blockade may have long term survival benefits over monotherapy, but may increase adverse effects and reduce quality of life in advanced prostate cancerH Akaza
Progress in Clinical and Biological Research|January 1, 1990
Response criteria in research protocols for prostatic cancerH Akaza
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 1, 1981
[The significance of lymphocytic infiltration in urologic tumors: studies of distributions of B and T-lymphocytes and its subsets, and functional analysis of the infiltrating lymphocytes (author's transl)]H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 14, 1997
[Development of new drugs for urological cancers]H Akaza
Current Opinion in Urology|September 27, 2000
Advances in chemotherapy of invasive bladder cancerH Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 4, 1999
[A new anti-androgen, bicalutamide (Casodex), for the treatment of prostate cancer--basic clinical aspects]H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 1999
[Recent advancement of the treatment of urological malignancies]H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1996
[Why is prostate cancer important in clinical field, now?]H Akaza
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|February 1, 1994
[TNM classification]H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1988
[Current status of the treatment of urothelial tumors]H Akaza
Pageof 30